Insmed Inc. sell klostergang
Start price
05.09.17
/
50%
€23.52
Target price
29.12.17
€16.24
Performance (%)
20.60%
End price
29.12.17
€28.36
Summary
This prediction ended on 29.12.17 with a price of €28.36. The SELL prediction by klostergang finished with a performance of 20.60%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Insmed Inc. | 0.000% | 0.000% | 235.784% | 185.417% |
| iShares Core DAX® | -0.372% | 5.236% | 16.908% | 16.016% |
| iShares Nasdaq 100 | -1.950% | 1.680% | 19.890% | 31.832% |
| iShares Nikkei 225® | -1.690% | 7.286% | 12.202% | 3.400% |
| iShares S&P 500 | -0.399% | 2.379% | 20.975% | 36.224% |
Comments by klostergang for this prediction
In the thread Insmed Inc. diskutieren
klostergang stimmt der Sell-Einschätzung von kyron7htx zu
The open-label design of the Phase 3 trial will likely have a negative impact on secondary outcomes and may hinder the robustness of Insmed's NDA.
(Vom Mitglied beendet)